The bronchial challenge with D. pteronyssinus enhanced pro-proliferative properties of inflammatory eosinophils subtype in allergic asthma patients Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Bronchial challenge with D. pteronyssinus changes the ratio of blood eosinophil subtypes and their biological properties in allergic asthma patients Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
LSC Abstract – Changes of peripheral blood eosinophil activity during allergen-induced late-phase airway inflammation in asthma Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016
IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003
Late-breaking abstract: Bronchial allergen challenge with D. Pteronyssinus inhibit blood neutrophil apoptosis in patients with allergic asthma and rhinitis Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease Year: 2011
Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure Source: Eur Respir J 2004; 24 : 750-757 Year: 2004
Markers of inflammation and airway responses to allergen in asthmatic patients Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2004; 24: Suppl. 48, 595s Year: 2004
The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Lower airway inflammation and hyperresponsiveness in allergic and non-allergic rhinitis Source: Annual Congress 2011 - Asthma: risk factors and comorbidities Year: 2011
A single nasal allergen challenge increases induced sputum inflammatory parameters in non-asthmatic patients with seasonal allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001
Relation of IgE, ECP and blood eosinophils to bronchial hyperreactivity in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 645s Year: 2007
Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006
Induced sputum eosinophils, bronchial reactivity and cough sensitivity in allergic rhinitis patients Source: Eur Respir J 2005; 26: Suppl. 49, 583s Year: 2005
Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001
Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019
Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006